Shared Mechanisms Allow SARS-CoV-2 Variants to Thrive Post-Vaccination
Convergent evolutionary mechanisms shared by COVID-19 variants allow them to overcome both adaptive and innate immune system barriers.
University of California San Francisco
Give to UCSF
Displaying 1 - 30 of 676
-
-
New COVID-19 Vaccines: Is it Worth the Shot?
Recommendations are in place for the updated COVID-19 vaccine from Pfizer-BioNTech and Moderna.
-
Protect Yourself and Loved Ones with the New RSV Vaccines
The FDA recently approved the world’s first vaccines to prevent RSV for infants and elderly adults.
-
Lancet Commission Calls for Renewed Global Response on TB
A new report from the Lancet Commission on tuberculosis releases recommendations, providing a path forward to turn the tide on this preventable, treatable and curable disease.
-
Rising COVID cases prompt Bay Area hospital to reinstate mask mandate
-
Not all COVID ‘Misinformation’ Is Equal – or Even Misinformation
-
Long COVID Symptoms Can Emerge Months After Infection
Long COVID symptoms can persist for a year after initial infection, or re-emerge months later after disappearing.
-
As a Summer Wave of COVID-19 Hits THE US, Questions About Vaccines, Quarantine and Testing Are Back
-
If You Never Got Sick From COVID, Thank Your Genes
-
Gene Mutation May Explain Why Some Don’t Get Sick from COVID-19
A common mutation can help people infected with the COVID-19 virus avoid developing any symptoms.
-
COVID-19 Vaccines Saved Dementia Patients’ Lives in Nursing Homes
Deaths among older adults with dementia fell starkly in nursing homes and long-term care centers after COVID-19 vaccinations became available, but remained high for those living at home.
-
Don’t Take Chances: Why Doxycycline is a Great Bet Against STIs
A short course of antibiotics, Doxy-PEP, can prevent some STIs after condomless sex.
-
With ‘Endemic,’ High-Profile S.F. Doctor Monica Gandhi Provides a Post-Mortem to the COVID Era
-
Bay Area Restaurateurs Grapple With Loss of Smell and Taste After Getting COVID-19
-
The Case of the Brain-Eating Amoeba
After diagnosing a middle-aged man with an incredibly rare and almost always fatal infection, a medical team led by UCSF fellow Natasha Spottiswoode raced to find a treatment that could save his life.
-
What’s New in the Search for a Long COVID Cure?
UCSF infectious disease specialist Michael Peluso, MD, who co-leads one of the world’s oldest studies of long COVID, discusses the condition’s mysteries.
-
Calling All Scientists to Fight the Next Pandemic
UCSF’s Nevan Krogan, PhD, is taking aim at the world’s deadliest diseases by uniting scientists and the biomedical industry to speed treatments.
-
Super-Engineered Vaccines Created to Help End Polio
-
COVID-19 Lessons Learned: ‘Why Aren’t We Working on All Diseases Like This?’
Quantitative Biosciences Institute’s Nevan Krogan reflects back on the COVID-19 pandemic and how internal and external communications, funding and international partnerships all contributed to a speedy COVID-19 response.
-
Two New Vaccines Join the Fight to Eradicate Polio
Two new oral polio vaccines will help limit the amount of new polio strains and outbreaks by genetically engineering weakened polio virus in the oral vaccine to reduce reversion to dangerous forms.
-
COVID-19 Masks: Expert Tips for What You Should (and Shouldn’t) Do
Face masks remain crucial in preventing the spread of COVID-19, even with vaccine availability. The decision to wear masks depends on vaccination status, risk factors, and local hospitalizations. Medical N95, KN95, or KF94 masks offer the best protection.
-
Is Heart Rate Behind Exercise Difficulty in Long Covid Patients?
While some patients recover from the effects of COVID-19, others experience the aftereffects long after the initial infection. UC San Francisco researchers are studying why some COVID-19 patients
-
Does Your Vaccine Type Matter in the Battle Against COVID?
COVID vaccine efficacy varied by age, BMI, sex, and smoking status, with levels changing over six months in a UCSF-led study. Pfizer and Moderna had higher antibody responses than Johnson & Johnson at one month, but Johnson & Johnson overtook them at six months.
-
UCSF Researchers Study Degrees of COVID-19 Vaccine Protection
-
Could Bird Flu Become the Next Pandemic?
Avian flu cases are spiking. Will it spill over into humans?
-
How a Morning-After-Style Pill Could Help Rising STD Cases
-
Norovirus Spreads Rapidly in California: How To Protect Yourself
-
Possible Culprit Identified in Outbreak of Severe Liver Damage Cases in Children
-
Severe Hepatitis Outbreak Linked to Common Childhood Viruses
A hepatitis outbreak in children occurred after COVID-19 lockdowns eased in 2022. Sudden exposure to a multitude of viruses upon reopening may have triggered this response in a small group of children.
-
White House Disbanding Its COVID-19 Team in May